<DOC>
	<DOC>NCT00901498</DOC>
	<brief_summary>The purpose of this study is to assess the bioavailability of four experimental formulations relative to the current reference formulation used in the Phase 2 study.</brief_summary>
	<brief_title>Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Young healthy male subjects Women</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>